Pharmagreen Biotech Inc   (PHBI)
Other Ticker:  
Price: $0.0007 $0.00 -12.500%
Day's High: $0.0007 Week Perf: -12.5 %
Day's Low: $ 0.00 30 Day Perf: 0.00
Volume (M): 2 52 Wk High: $ 0.01
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00

 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 445
 Employees -
 Revenues (TTM) (Millions $) 0
 Net Income (TTM) (Millions $) 2
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Pharmagreen Biotech Inc
Pharmagreen Biotech Inc is a biotechnology company that specializes in the production of high-quality medical cannabis. They aim to become a leading producer of pharmaceutical-grade cannabis through their innovative technology and sustainable cultivation practices. The company focuses on developing unique strains of cannabis that are tailored to specific medical conditions and provide optimal therapeutic benefits. Pharmagreen Biotech Inc also operates a cannabis tissue culture nursery, where they propagate and clone cannabis plants to ensure genetic consistency and maximize crop yields. They are committed to maintaining strict quality control standards to produce safe and effective cannabis products for the medical industry.

   Company Address: 2987 Blackbear Court Coquitlam 0 BC
   Company Phone Number: 803-9404   Stock Exchange / Ticker: PHBI


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Pharmagreen Biotech Inc

Pharmagreen Biotech Inc Announces Q2 2023 Revenue of $0.000963 Million

Pharmagreen Biotech Inc, a leading pharmaceutical company based in Canada, has reported a revenue of $0.000963 million in its second quarter of 2023. This financial report comes with the added news that the company's shortfall remains unchanged from the previous year, at $0.000 million.
While the company has not disclosed any details on what has contributed to its revenue growth in Q2, it is worth noting that Pharmagreen Biotech Inc was recently granted a hemp cultivation license by Health Canada. This license allows the company to cultivate and process industrial hemp, which has immense potential in the wellness and medical industries.


Pharmagreen Biotech Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com